The Cohesin Ring
================

In order to understand the function of cohesin, it is important to consider its motifs and structure. Cohesin forms a ring, consisting of two long coiled-coil proteins known as SMC proteins, a third component known as the kleisin subunit Rad21/Mcd1/Scc1 (hereafter referred to as Rad21), which closes the complex, and a fourth subunit Scc3/STAG of unclear function ([Fig. 1](#F1){ref-type="fig"}). Smc1 and Smc3 are ATP binding proteins that belong to the structural maintenance of chromosomes (SMC) family, which also includes condensin subunits (Smc2 and Smc4) and Smc5/6 complex components (Smc5 and Smc6). All SMC proteins help modulate chromosome structure and topology. SMC proteins are characterized by \~50 nanometer anti-parallel coiled coils flanked by a globular hinge domain and N and C-terminal domains. The N and C-terminal domains of SMC proteins contain conserved Walker A and Walker B motifs that come together to make an ATPase referred to as the head domain. ATPase activity is important for association of the cohesin complex with the chromosome and relocation of the cohesin ring along DNA.[@R2]^,^[@R3]

![**Figure 1.** Cohesin subunits are arranged to form a ring. The long coiled-coil Smc1 and 3 subunits are shown in blue and red, respectively, interacting at their hinge domain. The head domains of each subunit form an ATPase. The head domains are held together with the Scc1/Rad21/Mcd1 kleisin subunit (green). The Scc3/STAG subunit (yellow) associates with the kleisin. Adapted from reference [@R1].](rdis-2-e27743-g1){#F1}

Smc1 and Smc3 interact via their hinge domains. The head domains are held together by a kleisin subunit. Kleisins are a superfamily of bacterial and eukaryotic SMC protein partners.[@R4] The N terminus of Rad21 binds to the head domain of Smc3 while the C terminus binds to the head domain of Smc1,[@R5] which links the head of the SMC proteins. Electron microscopy reveals that the Smc1-Smc3 heterodimer forms a V-shaped structure.[@R5]^,^[@R6] Because Rad21 bridges the heads of Smc1 and Smc3, the three proteins are thought to form a circular complex.[@R5]^,^[@R7]^,^[@R8] The cohesin complex appears to be able to open and close via either the Smc1-Smc3 hinge domain interaction or the junction between the kleisin and the head domain.[@R9] Rad21 is cleaved by a protease prior to the onset of anaphase, allowing the cohesin ring to fall apart and the chromosomes to segregate.[@R10]^,^[@R11]

Cohesin associates with hundreds of regions within a genome.[@R12]^-^[@R14] One predominant association site is the pericentromeric region. At this region, cohesin binding opposes the spindle forces and allows chromosomes to orient on the spindle to ensure their accurate segregation. However, cohesin also binds at many other regions in the genome. In metazoans, cohesin is often found at the transcription start site of active genes and at enhancer regions, suggesting cohesin could play a role in transcription. Another region where cohesin is found in both prokaryotes and eukaryotes is the rDNA repeats. These repeats are highly transcribed by RNA polymerase I to make rRNAs that are structural components of the ribosome. While cohesion near centromeres appears to promote chromosome segregation, the role of cohesin at other regions of the genome is less clear, but is likely to influence replication, repair, transcription, and organization of the genome.

Cohesin Acetylation
===================

The opening and closing of the cohesin ring must be regulated in order to control its stability and association with chromatin throughout the cell cycle. Cohesin can interact with DNA in at least two modes, one of which is extremely stable and one of which is more transient. Both acetylation and sumoylation promote stable cohesin-DNA association in budding yeast. Phosphorylation of cohesin subunits can promote or destroy cohesion, depending on the context.[@R1] Both the acetylation mechanism for promoting stable cohesin-DNA interactions and the acetyltransferase are evolutionarily conserved from yeast to human cells. Eco1 (establishment of cohesion) was first discovered in budding yeast as an acetyltransferase required for the establishment of cohesion during S phase.[@R15]^,^[@R16] Eco1 interacts with replication fork components[@R17] and may travel with replication forks to acetylate cohesin complexes during S phase to promote cohesion.[@R18]

The target of Eco1 acetylation are lysines 112 and 113 in yeast Smc3.[@R19]^-^[@R21] This acetylation event appears to lock the ring into a stable DNA association mode. When these residues are acetylated, interactions between Smc3 and anti-establishment factors such as Pds5 and Wapl are disrupted, allowing cohesion to be established in S phase.[@R22]^,^[@R23] Deacetylation of Smc3 by Hos1 (known as HDAC8 in human) is also important for recycling Smc3 for the next cell cycle.[@R24]^-^[@R26] In addition to cohesion establishment, acetylation plays an important role in DNA damage repair. Instead of Smc3, Eco1 acetylates the kleisin subunit Rad21 in response to a DNA double-strand break to promote cohesion both at the break site and genome-wide.[@R19]^,^[@R27]^-^[@R31]

Budding yeast only contain a single enzyme, Eco1, to acetylate cohesin. Mammalian cells have two enzymes, ESCO1 and ESCO2, both implicated in sister chromatid cohesion.[@R32] This begs the question as to which are the unique and which are the overlapping actions of these two enzymes. Although both are acetyltransferases, knockdown of ESCO1 reduces the acetylation of lysines 105 and 106 on Smc3 more than knockdown of ESCO2,[@R33] suggesting ESCO1 is responsible for the bulk of Smc3 acetylation on these lysines. ESCO1 acetylation of Smc3 is important for cell survival in response to ionizing radiation-induced DNA damage, in association with genome-wide reinforcement of cohesin binding in the G2/M cell cycle phase.[@R34] ESCO2 mutant cells are also sensitive to DNA damage, suggesting ESCO2 also functions as part of the DSB repair response.[@R35] While our current understanding of the functional overlap of these two enzymes is poor, insight into their function will help us understand regulation of cohesin association throughout the genome

Roberts Syndrome
================

The developmental disorder known as Roberts syndrome (RBS) is caused by mutations in ESCO2 that eliminate its acetyltransferase activity.[@R36]^,^[@R37] RBS patients have growth and mental retardation, limb deformities, and craniofacial defects. Deacetylated cohesin represents the unstable form which is not fully capable of holding sisters together. Metaphase chromosome spreads from RBS patients show heterochromatic repulsion,[@R37] suggesting the possibility that ESCO2 is especially important for cohesion at these regions ([Fig. 2](#F2){ref-type="fig"}). In mouse cells, ESCO2 associates with pericentric heterochromatin and depletion leads to reduced cohesin acetylation, lagging chromosomes, and increased apoptosis.[@R38] In contrast to the case in humans, loss of ESCO2 in mice is lethal. ESCO1 has never been reported to be mutated in association with human disease, possibly because mutations in this gene would be lethal.

![**Figure 2.** Chromosomes derived from a metaphase spread of a RBS patient cell show repulsion at heterochromatic regions, which includes pericentromeric regions and rDNA. We speculate that the acetylation activity of ESCO2 is necessary for cohesion of these regions. Although both chromosomes are derived from the same metaphase spread presented in Vega et al. (2005),[@R37] the one on the left appears normal while the one on the right shows repulsion.](rdis-2-e27743-g2){#F2}

Because heterochromatic domains are difficult to replicate, it is possible that there is a cohesin acetyltransferase devoted to establishing cohesion in these regions in mammalian cells. The regions with heterochromatic repulsion in human RBS cells include pericentric domains and nucleolar organizing regions (NORs or rDNA). While the repulsion at pericentric domains might be predicted to cause chromosome missegregation and aneuploidy that could contribute to cell death, it remains to be determined if these contribute to the disease etiology. Gene expression is clearly disrupted and contributes to the etiology of both RBS and related cohesinopathies, although the mechanisms behind the changes in gene expression are not clear.[@R39]

A budding yeast strain with a mutation in *ECO1* that genocopies an RBS allele was found to have defects in nucleolar organization, transcription and cohesion of the rDNA, and translation.[@R40]^,^[@R41] Cohesion within the rDNA appears to promote nucleolar structure and function in budding yeast. In budding yeast the rDNA is present in 100--200 copies at a single locus. At any given moment, about half of the repeats are highly transcribed by RNA polymerase I to produce the rRNAs that become structural components of ribosomes. These RNAs can be limiting for ribosome formation.[@R42] The repeats form loops[@R43] that are reduced in budding yeast bearing an RBS mutation, although RNA polymerase I occupancy remained normal (see [Fig. 3](#F3){ref-type="fig"} for a model of the role of cohesion at the rDNA). Furthermore, depletion or artificial destruction of cohesion in a single cell cycle was associated with loss of nucleolar integrity.[@R45] Given these observations in budding yeast, we wondered whether nucleolar deficits would accompany ESCO2 mutation in human RBS cells. In human cells there are 5 chromosomes with rDNA repeats. RBS cells have profound defects in transcription of the rDNA and ribosome production.[@R40] Furthermore, the nucleolus is highly fragmented[@R46] ([Fig. 4](#F4){ref-type="fig"}). This leads to global changes in gene expression and cell physiology[@R47] (Xu and Gerton, unpublished).

![**Figure 3.** A model for the role of cohesion within the nucleolus. Cohesin binding to the rDNA repeats is evolutionarily conserved from bacteria to human cells. In budding yeast, cohesin binds to the non-transcribed region between repeats[@R44] in such a way that it could trap loops of 35S genes. The 35S gene is transcribed by RNA polymerase I and then cleaved and modified by the processome to make 18S, 5.8S, and 25S rRNAs that are included in the large (60S) and small (40S) ribosomal subunits. RNA polymerase III transcribes the 5S RNA that is included in the large ribosomal subunit. Cohesion at this region could promote transcription by RNA polymerase I as well as the overall structural formation of the nucleolus.](rdis-2-e27743-g3){#F3}

![**Figure 4.** RBS patient cells have highly fragmented nucleoli. Skin cells from patients with RBS display defects in the organization of nucleoli (red arrow), specialized nuclear subdomains dedicated to the production of ribosomes. Fibrillarin, a nucleolar marker stained with an anti-fibrillarin antibody, is shown in green. DNA is stained with DAPI, shown in blue. Colors were adjusted for improved visual presentation. The scale bar is 10 µm. Top, RBS cells; bottom, normal cells.](rdis-2-e27743-g4){#F4}

mTORC1 is a protein kinase that senses cellular stress, such as amino acid deprivation, and responds by shutting down protein translation. Given the translation defects in RBS cells, we examined the mTOR pathway. Based on several key effector proteins, we found that the TOR pathway was inhibited and p53 was activated in RBS cells. A zebrafish model for RBS showed that depletion of ESCO2 was associated with disruption of the cell cycle and high levels of apoptosis.[@R48] Using zebrafish RBS models, we found that the mTOR and p53 pathways were inhibited and activated, respectively, as observed in human RBS cells.[@R46] Stimulation of the TOR pathway with [l]{.smallcaps}-leucine helped to rescue both protein synthesis and cell division and block cell death.[@R46] At the organismal level, [l]{.smallcaps}-leucine had a substantial rescue effect on the development of zebrafish RBS embryos, suggesting that many of the transcriptional changes could be rescued by boosting translation ([Fig. 5](#F5){ref-type="fig"}). The fact that [l]{.smallcaps}-leucine can push the TOR pathway to work harder also suggests that the basic machinery needed to make ribosomes and carry out translation is intact in RBS cells.

![**Figure 5.**[l]{.smallcaps}-leucine treated RBS zebrafish show improved development. A morpholino to ESCO2 (ESCO2-MO) or a control morpholino (ESCO2--5mis) was used for knock down in wild type embryos at the 1--2 cell stage. Following microinjection, embryos were incubated with 4 mM L-glutamine plus either 10 mM [d]{.smallcaps}-leucine, which is biologically inactive, or 10 mM [l]{.smallcaps}-leucine for 2 d post fertilization (dpf) and then photographed. L-glutamine assists in uptake of leucine. The scale bar is 2 mm.](rdis-2-e27743-g5){#F5}

In the future, it will be interesting to quantify the extent to which translational changes drive differential gene expression in RBS.[@R49] An experiment performed in *eco1* mutant budding yeast in which poor rRNA production was corrected by deletion of *FOB1* reveals that the differential expression of hundreds of genes is also corrected.[@R50] This experiment suggests that a substantial portion of the differential gene expression associated with a mutation in *ECO1* in budding yeast is due to defects at the rDNA locus and reduced translation.

Cornelia de Lange Syndrome and Cancer
=====================================

Cornelia de Lange syndrome (CdLS) is a genetically dominant disorder caused by the mutation of one copy of NIPBL, SMC1, SMC3, or HDAC8.[@R51]^-^[@R57] A related disorder is caused by mutation of RAD21.[@R58] These mutations affect the cohesin ring (SMC1, SMC3, RAD21), the deacetylation of the ring (HDAC8), or the loading of the ring (NIPBL). CdLS is characterized by growth and mental retardation, limb deformities, and craniofacial defects. The severity of CdLS can range from a mild disorder of the nervous system to a severe multisystem disorder. About 60% of CdLS cases are caused by mutations in NIPBL, a loading factor for the cohesin complex. While gene expression is clearly disrupted and contributes to the etiology of CdLS, the underlying mechanism is unclear.[@R59] Many models posit that cohesin binding at a given locus has direct effects on its transcription. Because cohesin binds at many sites in the genome, a mutation in cohesin has the potential to affect the transcription of hundreds of genes. However, translational changes such as those associated with RBS would also be expected to affect the transcription and translation of many genes.

We speculate that mutations in ESCO2 may affect a particular pool of cohesin, the cohesin at heterochromatic regions. When cohesion at the rDNA is reduced, nucleolar structure is disrupted and nucleolar function is less efficient, with an accompanying deficit in the TOR pathway. In contrast, mutations that cause CdLS may affect cohesin throughout the genome, unless the mutation compromises protein-protein or protein-DNA interactions that occur at specific cohesin associated regions. These mutations could have anywhere from undetectable to severe effects on the pool of cohesin at the rDNA and on nucleolar function. In budding yeast, a mutation in *SMC1* that genocopies a mutation associated with CdLS causes nucleolar phenotypes that are milder than the *ECO1* mutation,[@R40]^,^[@R41] suggesting some CdLS mutations may be associated with mild defects in nucleolar function. In zebrafish models for CdLS, some mutations appear to be associated with more growth delay and apoptosis than others;[@R48]^,^[@R60]^-^[@R63] nucleolar function has not been analyzed. However, if nucleolar function is affected by non-ESCO2 mutations, this could potentially contribute to the gene expression changes associated with CdLS. Furthermore, if translation is not operating at full capacity, [l]{.smallcaps}-leucine might be able to stimulate mTOR to help rescue translation and some of the differential gene expression associated with CdLS.

Translational defects are associated with both human developmental disorders and cancer.[@R64]^,^[@R65] A recent study found that 13% of acute myeloid leukemia (AML) cases were caused by mutations in cohesin genes, including RAD21, STAG2, SMC1, and SMC3.[@R66] In general, AML is not associated with abnormal karyotypes, raising the possibility that the cohesin mutations are causing transcriptional or translational changes that lead to AML, and emphasizing the need to understand the molecular origin of these changes. If we can understand the contribution of translational mechanisms and particular key regulatory pathways, such as p53 and mTOR, in Roberts syndrome and CdLS, we might also understand how cohesin mutations lead to myeloid neoplasms.[@R66]^,^[@R67]

No potential conflict of interest was disclosed.

We thank Richard Shrock and Mark Miller for assistance in manuscript and figure preparation.

XuBLeeKKZhangLGertonJL Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome PLoS Genet 2013 9 e1003857 10.1371/journal.pgen.1003857

[10.4161/rdis.27743](10.4161/rdis.27743)
